[Efficacy and tolerability of thymopoietin in patients at risk of infection].
D000386:AIDS-Related Complex / Q000150:complications; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001424:Bacterial Infections / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000150:complications; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications; D010446:Peptide Fragments / Q000009:adverse effects / Q000627:therapeutic use*; D011897:Random Allocation; D012008:Recurrence; D016305:Thymopentin; D013946:Thymopoietins / Q000009:adverse effects / Q000627:therapeutic use*; D013951:Thymus Hormones / Q000627:therapeutic use*; D014374:Tuberculin Test
D010446:Peptide Fragments; D013946:Thymopoietins; D013951:Thymus Hormones; D016305:Thymopentin
Efficacia e tollerabilità della timopentina in pazienti a rischio di infezioni. GISOT (Gruppo Italiano di Studio sugli Ormoni Timici).